GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Accolade Inc (NAS:ACCD) » Definitions » Days Payable

Accolade (Accolade) Days Payable : 16.54 (As of Nov. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Accolade Days Payable?

Accolade's average Accounts Payable for the three months ended in Nov. 2023 was $9.9 Mil. Accolade's Cost of Goods Sold for the three months ended in Nov. 2023 was $54.5 Mil. Hence, Accolade's Days Payable for the three months ended in Nov. 2023 was 16.54.

The historical rank and industry rank for Accolade's Days Payable or its related term are showing as below:

ACCD' s Days Payable Range Over the Past 10 Years
Min: 11.14   Med: 16.48   Max: 24.67
Current: 15.4

During the past 6 years, Accolade's highest Days Payable was 24.67. The lowest was 11.14. And the median was 16.48.

ACCD's Days Payable is ranked worse than
87.1% of 589 companies
in the Healthcare Providers & Services industry
Industry Median: 61.58 vs ACCD: 15.40

Accolade's Days Payable declined from Nov. 2022 (19.08) to Nov. 2023 (16.54). It may suggest that Accolade accelerated paying its suppliers.


Accolade Days Payable Historical Data

The historical data trend for Accolade's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accolade Days Payable Chart

Accolade Annual Data
Trend Feb18 Feb19 Feb20 Feb21 Feb22 Feb23
Days Payable
Get a 7-Day Free Trial 12.31 19.14 24.67 16.44 16.51

Accolade Quarterly Data
Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.08 18.00 13.14 10.36 16.54

Competitive Comparison of Accolade's Days Payable

For the Health Information Services subindustry, Accolade's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Accolade's Days Payable Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Accolade's Days Payable distribution charts can be found below:

* The bar in red indicates where Accolade's Days Payable falls into.



Accolade Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Accolade's Days Payable for the fiscal year that ended in Feb. 2023 is calculated as

Days Payable (A: Feb. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Feb. 2022 ) + Accounts Payable (A: Feb. 2023 )) / count ) / Cost of Goods Sold (A: Feb. 2023 )*Days in Period
=( (7.837 + 10.155) / 2 ) / 198.905*365
=8.996 / 198.905*365
=16.51

Accolade's Days Payable for the quarter that ended in Nov. 2023 is calculated as:

Days Payable (Q: Nov. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Aug. 2023 ) + Accounts Payable (Q: Nov. 2023 )) / count ) / Cost of Goods Sold (Q: Nov. 2023 )*Days in Period
=( (7.098 + 12.667) / 2 ) / 54.518*365 / 4
=9.8825 / 54.518*365 / 4
=16.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Accolade Days Payable Related Terms

Thank you for viewing the detailed overview of Accolade's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Accolade (Accolade) Business Description

Traded in Other Exchanges
Address
1201 Third Avenue, Suite 1700, Seattle, WA, USA, 98101
Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. It generates revenue by providing personalized health guidance solutions to members.
Executives
Richard Eskew officer: EVP General Counsel C/O ACCOLADE, INC., 660 WEST GERMANTOWN PIKE, SUITE 500, PLYMOUTH MEETING PA 19462
Stephen H. Barnes officer: Chief Financial Officer C/O ACCOLADE, INC., 660 WEST GERMANTOWN PIKE, SUITE 500, PLYMOUTH MEETING PA 19462
Rajeev Singh director, officer: Chief Executive Officer 6222 185TH AVENUE NE, REDMOND WA 98052
Robert N Cavanaugh officer: President 1601 CLOVERFIELD BLVD., SUITE 620, SANTA MONICA CA 90404
Mchugh Colin officer: Chief Accounting Officer C/O ACCOLADE, INC., 660 W. GERMANTOWN PIKE, SUITE 500, PLYMOUTH MEETING PA 19462
Michael W Hilton officer: Chief Product Officer 6222 185TH AVE, REDMOND WA 98052
Peter S Klein director C/O MICROSOFT CORPORATION, ONE MICROSOFT WAY, REDMOND WA 98052-6399
Cindy Kent director 7601 PENN AVENUE SOUTH, RICHFIELD MN 55418
Patricia L Wadors director C/O ALIGN TECHNOLOGY INC, 881 MARTIN AVE, SANTA CLARA CA 95050
Dawn G Lepore director 1425 BROADWAY PMB 41, SEATTLE WA 99122
Jeffrey D Jordan director 2865 SAND HILL ROAD #101, MENLO PARK CA 94025
Elizabeth G Nabel director BRIGHAM AND WOMEN'S HOSPITAL, 75 FRANCIS ST, BOSTON MA 02115
Jeffrey S Brodsky director C/O MORGAN STANLEY 1585 BROADWAY, NEW YORK NY 10036
Thomas J Neff director SPENCER STUART & ASSOCIATES, 277 PARK AVE, NEW YORK NY 10172
William H. Frist director 600 MONTGOMERY STREET, SAN FRANCISCO CA 94111

Accolade (Accolade) Headlines

From GuruFocus

Accolade to Webcast Analyst Day on May 8, 2023

By sperokesalga sperokesalga 04-24-2023

Accolade Announces Upcoming Investor Events

By sperokesalga sperokesalga 05-08-2023

Accolade Inc CEO Rajeev Singh Sells 1,456 Shares

By GuruFocus Research 05-26-2023

Accolade Inc CEO Rajeev Singh Sells 1,578 Shares

By GuruFocus Research GuruFocus Editor 05-25-2023

Accolade Inc CFO Stephen Barnes Sells 640 Shares

By GuruFocus Research GuruFocus Editor 05-25-2023

Accolade Inc CEO Rajeev Singh Sells 7,622 Shares

By GuruFocus Research 06-15-2023